To support the change in legislation from April 6th 2022, the MED3 (Statement of Fitness for Work) created by both Vision 3 and Vision Anywhere has been updated
Latest News
We are aware that our Help Centres across all products are currently unavailable. We are working to rectify this issue as soon as possible and will notify you via this feed once they are back on line. We are sorry for any inconvenience caused.
When you prescribe high risk drug Sodium Valproate to females, there must be a warning to ensure contraception is provided in view of the significant risks of birth defects and developmental disorders that could occur in children through its use during pregnancy. This applies to females of childbearing age.
We are interested to learn about how your nurses/admin team use Immunisation Due Dates in Vision 3.
SIS 10610 delivers new features for England, Wales and Northern Ireland and a number of user-requested enhancements.
Clinical Safety issue where a KIS Special Note recorded for patients registered at Vision GP practices may not be the most recent version of that data
Issue with prescribing generic drugs that are parallel import items using Vision.
Data Update for Vision Anywhere users in Wales
Information about the Daily Import of Influenza Vaccination Data. We are now automatically importing data received from external vaccination systems into patient records in Vision 3.
Advisory post highlighting the potential for divergence between drug-drug interaction warning severity levels assigned by Cegedim Healthcare Solutions and those included in the BNF and Stockley’s information for interactions.